Veeva Systems (VEEV) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Veeva Systems (VEEV) do?
Veeva Systems Inc (VEEV) is a U.S.-listed company in Healthcare (Health Information Services). What it does: Sells cloud-based software subscriptions and data services to pharmaceutical and biotechnology companies. Operates specialized cloud software and data systems built specifically for life sciences regulatory compliance and. It is worth $42.57B on the market and sold $3.46B over the last year.
- Market cap
- $42.57B
- P/E ratio
- 43.3×
- Annual sales
- $3.46B
- Sector
- Healthcare
- Industry
- Health Information Services
- Brief updated
- Nov 08, 2026
Brands and businesses behind VEEV
- Veeva Vault: Cloud platform generating recurring subscription fees by managing clinical trials and regulatory documentation for life sciences firms.
- Veeva Crossix: Health data platform earning subscription fees by measuring the audience impact of pharmaceutical marketing campaigns.
- Veeva Compass: Healthcare data product selling longitudinal prescription and patient data feeds to commercial teams.
- Veeva OpenData: Reference database offering verified customer profiles of healthcare professionals through annual data licenses.
VEEV’s flags, in plain English
Each flag is a number from Veeva Systems’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 08, 2026.
Stupid Cash
Can pay this year's bills 5.5 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Low debt
Low debt, only 2% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.
Wide Gross Margin
Gross margin of 74.8% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Priced for Perfection
Priced at 43.3 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.
2 more green flags open with the free trial. Try it free for 7 days.
Questions about VEEV
How big is Veeva Systems?
Veeva Systems’ market cap is $42.57B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $3.46B: what customers paid the company over the last year, before any costs.
What is VEEV’s P/E ratio?
VEEV’s P/E ratio is 43.3×. Investors pay about 43.3 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with VEEV?
Revenue concentration exists among major global pharmaceutical corporations that face cyclical drug trial pipelines. That is one risk on Veeva Systems’ card. Its first risk flag is Priced for Perfection, explained above. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Veeva Systems’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. VEEV’s filings on SEC.gov. The Margin Monkey is research, not advice.
